Latest On Sysmex Corporation (SSMXF):
About Sysmex Corporation (SSMXF):
Sysmex Corporation, together with its subsidiaries, engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. The company offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. It also provides urine formed sediment analysis systems; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS. In addition, the company offers cancer lymph node metastasis testing systems to detect information to help in diagnosing lymph node metastasis; cancer genome profiling systems; and cytogenic testing and lab assay services. It is also involved in the development and sale of software for diagnostic information systems; provision of facility management, office, and welfare services; development, manufacture, and sale of nucleic acid analogs; development, operation, and maintenance of IT solutions, platforms, and applications related to digital medicine; marketing, development, design, manufacture, sale, and after-sales service related to medical robots; and distribution and after sales support of medical devices and reagents for biotechnology, medical technology, and molecular cell analysis. The company serves national and other public hospitals, private hospitals, universities, research institutes, other medical institutions, etc. It also exports its products to approximately 190 countries. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.
General
- Name Sysmex Corporation
- Symbol SSMXF
- Type Common Stock
- Exchange PINK
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDiagnostics & Research
- Full Time Employees 8,200
- Last Split Factor2:1
- Last Split Date2014-03-27
- Fiscal Year EndMarch
- Web URLhttp://www.sysmex.co.jp
Valuation
- Trailing PE 72.07
- Forward PE 61.35
- Price/Sales (Trailing 12 Mt.) 9.35
- Price/Book (Most Recent Quarter) 9.5
- Enterprise Value Revenue 0.07
- Enterprise Value EBITDA 0.31
Financials
- Most Recent Quarter 2020-12-31
- Profit Margin 11%
- Return on Assets 8%
- Return on Equity 11%
- Earnings Per Share $1.72
- Revenue Per Share $0
- Gross Profit 159.81 billion
- Quarterly Earnings Growth 6.1%
ESG Rating
Highlights
- Market Capitalization 21.6 billion
- Book Value Per Share $11.05
Share Statistics
- Shares Outstanding 208.97 million
- Shares Float 172.9 million
- % Held by Insiders 2683%
- % Held by Institutions 30.03%
Technicals
- Beta 0.38
- 52 Week High $128.75
- 52 Week Low $66.62
- 50 Day Moving Average 123.75
- 200 Day Moving Average 100.45
Dividends
- Forward Annual Dividend Rate $0.67
- Forward Annual Dividend Yield 0.54%
- Payout Ratio 65%
- Dividend Date 2018-06-25
- ExDividend Date 2021-03-30
- Dividend Per Share $0.58
- Dividend Yield 0%
Sysmex Corporation (SSMXF) Dividend Calendar:
SSMXF's last dividend payment was made to shareholders on June 25, 2018.
Sysmex Corporation pays out 65% of its earnings out as a dividend.
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
Sysmex Corporation (SSMXF) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-12-31 | 2020-12-31 | $N/A | $0.49 | ||
2020-09-30 | 2020-12-31 | $N/A | $0.49 | $40.36 | -98.78% |
2020-06-30 | 2020-09-30 | $N/A | $0.37 | $20.32 | -98.18% |
2020-03-31 | 2020-06-30 | $N/A | $0.20 | $57.27 | -99.65% |
2019-12-31 | 2020-03-31 | $75.17 billion | $0.37 | $51.89 | -99.28% |
2019-09-30 | 2019-12-31 | $74.45 billion | $0.39 | $49.94 | -99.22% |
2019-06-30 | 2019-09-30 | $68.54 billion | $0.48 | $42.56 | -98.87% |
2019-03-31 | 2019-06-30 | $85.13 billion | $0.30 | $53.82 | -99.45% |
2018-12-31 | 2019-03-31 | $72.18 billion | $0.53 | $51.38 | -98.96% |
2018-09-30 | 2018-12-31 | $70.23 billion | $0.41 | $54.70 | -99.25% |
2018-06-30 | 2018-09-30 | $76.77 billion | $0.42 | $49.14 | -99.14% |
2018-03-31 | 2018-06-30 | $79.38 billion | $0.41 | $53.17 | -99.23% |
2017-12-31 | 2018-03-31 | $71.44 billion | $0.39 | $52.21 | -99.25% |
2017-09-30 | 2017-12-31 | $81.41 billion | $0.48 | $45.34 | -98.93% |
2017-06-30 | 2017-09-30 | $2.03 billion | $0.47 | $43.23 | -98.92% |
2017-03-31 | 2017-06-30 | $69.11 billion | $0.35 | $52.30 | -99.33% |
2016-12-31 | 2017-03-31 | $61.99 billion | $0.37 | $46.78 | -99.2% |
2016-09-30 | 2016-12-31 | $0.35 | $43.53 | -99.2% | |
2016-06-30 | 2016-09-30 | $0.66 | $35.11 | -98.11% | |
2016-03-31 | 2016-06-30 | $0.44 | $54.30 | -99.19% | |
2015-12-31 | 2016-03-31 | $0.39 | $42.70 | -99.09% | |
2015-09-30 | 2015-12-31 | $0.41 | $46.63 | -99.12% | |
2015-06-30 | 2015-09-30 | $0.37 | |||
2015-03-31 | 2015-06-30 | $0.29 | $38.48 | -99.24% | |
2014-12-31 | 2015-03-31 | $0.24 | $32.22 | -99.25% | |
2014-09-30 | 2014-12-31 | $0.32 | $29.93 | -98.94% | |
2014-06-30 | 2014-09-30 | $0.33 | |||
2014-03-31 | 2014-06-30 | $0.25 | |||
2013-12-31 | 2014-03-31 | $0.31 | |||
2013-09-30 | 2013-12-31 | $0.25 | |||
2013-06-30 | 2013-09-30 | $0.27 | |||
2013-03-31 | 2013-06-30 | $0.15 | |||
2012-12-31 | 2013-03-31 | $0.24 | |||
2012-09-30 | 2012-12-31 | $0.18 | |||
2012-06-30 | 2012-09-30 | $0.25 | |||
2012-03-31 | 2012-06-30 | $0.14 | |||
2011-12-31 | 2012-03-31 | $0.20 | |||
2011-09-30 | 2011-12-31 | $0.17 | |||
2011-06-30 | 2011-09-30 | $0.26 | |||
2011-03-31 | 2011-06-30 | $0.10 | |||
2010-12-31 | 2011-03-31 | $0.20 | |||
2010-09-30 | 2010-12-31 | $0.15 | |||
2010-06-30 | 2010-06-30 | $0.09 | |||
2008-12-31 | 2008-12-31 | $0.06 | |||
2008-09-30 | 2008-09-30 | $0.10 | |||
2008-06-30 | 2008-06-30 | $0.07 |
Sysmex Corporation (SSMXF) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
---|---|---|---|---|---|
Research Development | N/A | N/A | N/A | N/A | 5.73 billion |
Income Before Tax | N/A | N/A | N/A | N/A | 12.15 billion |
Selling General Administrative | N/A | N/A | N/A | N/A | 21.72 billion |
Gross Profit | N/A | N/A | N/A | N/A | 40.17 billion |
Ebit | N/A | N/A | N/A | N/A | 12.62 billion |
Operating Income | N/A | N/A | N/A | N/A | 12.62 billion |
Income Tax Expense | 4.6 billion | 3.47 billion | 2.04 billion | 3.76 billion | 3.24 billion |
Total Revenue | N/A | N/A | N/A | N/A | 75.17 billion |
Cost of Revenue | N/A | N/A | N/A | N/A | 35 billion |
Total Other Income Expense Net | N/A | N/A | N/A | N/A | -466 million |
Net Income From Continuing Operations | N/A | N/A | N/A | N/A | 8.91 billion |
Net Income Applicable to Common Shares | 10.64 billion | 8.17 billion | 4.49 billion | 8.39 billion | 8.9 billion |
Cash Flow:
Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
---|---|---|---|---|---|
Investments | N/A | N/A | N/A | -1.85 billion | -396 million |
Change to Liabilities | -1.22 billion | -3.76 billion | 2.4 billion | 2.74 billion | 1.83 billion |
Total Cash Flow from Investing Activities | -6.49 billion | -8.62 billion | -7.91 billion | -8.94 billion | -8.49 billion |
Net Borrowings | N/A | N/A | N/A | N/A | N/A |
Total Cash Flow from Financial Activities | N/A | N/A | N/A | -8.81 billion | -1.32 billion |
Change to Operating Activities | 1.1 billion | -2.88 billion | 684 million | 1.74 billion | -625 million |
Change in Cash | N/A | N/A | N/A | -8.29 billion | 8.62 billion |
Total Cash from Operating Activities | 13.92 billion | 9.9 billion | 18.03 billion | 8.25 billion | 19.17 billion |
Depreciation | N/A | N/A | N/A | 6.3 billion | 5.75 billion |
Other Cash Flow from Investing Activities | -609 million | -1.48 billion | -626 million | -904 million | -155 million |
Change to Inventory | N/A | N/A | N/A | -5.45 billion | -2.21 billion |
Change to Account Receivables | N/A | N/A | N/A | -1.44 billion | -925 million |
Other Cash Flow from Financing Activities | -1.41 billion | -1.57 billion | -1.94 billion | -1.29 billion | -1.32 billion |
Change to Net Income | -1.35 billion | -5.59 billion | 1.74 billion | -7.79 billion | -61 million |
Capital Expenditures | N/A | N/A | N/A | 2.67 billion | 4.2 billion |
Balance Sheet:
Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
---|---|---|---|---|---|
Total Liabailities | N/A | N/A | N/A | N/A | 99.87 billion |
Total Stockholder Equity | N/A | N/A | N/A | N/A | 273.89 billion |
Other Current Liabilities | 25.3 billion | 22.73 billion | N/A | N/A | 20.99 billion |
Total Assets | N/A | N/A | N/A | N/A | 374.37 billion |
Common Stock | 13.14 billion | 13.03 billion | 12.97 billion | 12.88 billion | 12.79 billion |
Other Current Assets | 13.89 billion | 11.21 billion | N/A | N/A | 13.18 billion |
Retained Earnings | 269.57 billion | 266.46 billion | 258.29 billion | 261.32 billion | 252.91 billion |
Other Liabilities | 10.59 billion | 10.05 billion | 9.62 billion | 9.87 billion | 8.97 billion |
Other Assets | 6.7 billion | 6.8 billion | 7.15 billion | 7.25 billion | 6.52 billion |
Cash | N/A | N/A | N/A | N/A | 48.7 billion |
Total Current Liabilities | 75.21 billion | 68.54 billion | N/A | N/A | 73.82 billion |
Other Stockholder Equity | -10.9 billion | -12.97 billion | -14.18 billion | -14.7 billion | -9.72 billion |
Property, Plant & Equipment | 93.74 billion | 94.33 billion | 95.4 billion | 96.84 billion | 96.71 billion |
Total Current Assets | 205.59 billion | 196.34 billion | N/A | N/A | 195.06 billion |
Long Term Investments | N/A | N/A | N/A | N/A | 27.43 billion |
Net Tangible Assets | 235.36 billion | 231.79 billion | 224.1 billion | 226.87 billion | 225.24 billion |
Short Term Investments | N/A | N/A | N/A | N/A | N/A |
Long Term Debt | N/A | N/A | N/A | N/A | N/A |
Inventory | 50.45 billion | 50.53 billion | N/A | N/A | 51.41 billion |
Accounts Payable | 27.36 billion | 23.53 billion | N/A | N/A | 30.65 billion |
Sysmex Corporation (SSMXF) Chart:
Sysmex Corporation (SSMXF) News:
Below you will find a list of latest news for Sysmex Corporation (SSMXF) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Sysmex Corporation (SSMXF) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|
Sysmex Corporation (SSMXF) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2011-04-01 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1517231/000101915511000190/0001019155-11-000190-index.htm |
2011-04-20 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1517231/000119380511000755/0001193805-11-000755-index.htm |
2012-10-16 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1517231/000119380512001698/0001193805-12-001698-index.htm |
2013-02-27 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1517231/000119380513000548/0001193805-13-000548-index.htm |
2017-09-29 | F-6 POS | Post-effective amendments for immediately effective filing | https://www.sec.gov/Archives/edgar/data/1517231/000119380517003002/0001193805-17-003002-index.htm |
2019-11-22 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1517231/000119380519001545/0001193805-19-001545-index.htm |
2014-10-16 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1517231/000157104914005166/0001571049-14-005166-index.htm |